Pakistan allocates $100m to purchase Covid-19 vaccine

Nellie Chapman
November 20, 2020

On the question of prioritisation, Vardhan said that tentative guidelines have been formed to administer the vaccine to priority groups keeping the scientific approach as the ground. In the webinar titled "Changing Health Paradigm during and After Kovid", Harsh Vardhan said that the Kovid-19 vaccine will be available in the next few months and it is expected that 40-50 for 25-30 crore people by July-August next year.

Any distribution of vaccines would also require approval from the country's medical watchdog, the MHRA.

'What we would have to do in March-April next year, we have started planning for it from now only, ' Vardhan said.
We have made a detailed, careful plan about it.

The minister said, "We have also initiated an integrated response system against COVID-19 and will also host clinical trials for all the major vaccines". About 20 vaccines are in different stages of development'.

"Potential Covid-19 vaccines could need to be delivered within a certain time period once they arrive at a site", the slide said.

"You can protect yourself from this deadly virus with small precautions like wearing a good quality mask properly, maintaining social distance and taking care of hand-hygiene", he noted. Meanwhile, Ahmedabad-based Cadila Healthcare is now finishing phase-II trials of its vaccine candidate.

How Dolly Parton feels about helping create a vaccine
The icon made headlines in April with the major donation to Vanderbilt University Medical Center in honor of her friend, Dr. Speaking to NBC News, she said: "I'm just happy that anything I do can help somebody else". "Evidently, it is.

Phase-3 clinical trial of the vaccine developed by the Indian Council of Medical Research (ICMR) has already begun.

The new figures from 170 participants in their phase III clinical trial show the jab was 95 per cent effective in preventing Covid-19, with a 94 per cent effectiveness in those aged 65 and over.

Biological E Limited has started early phase 1 and 2 human trials of its COVID-19 vaccine candidate. Although global firms - Pfizer and BioNTech - have announced that the phase-III clinical trials of their vaccines had shown 90 percent efficacy in preventing the disease among those who have not contracted the virus, they are in the process of compiling the data.

English doctors are grappling with the prospect of seven-day service, -75 degree Celsius freezers and vaccines known as "Talent" and "Courageous" as they prepare for an unprecedented logistical challenge: the roll-out of COVID-19 vaccinations.

The onerous storage requirements of the Pfizer vaccine can be mitigated by dry ice and other temporary cooling solutions, said Anna Blakney, research fellow at Imperial College London.

Other reports by

Discuss This Article